Global Coronavirus Immunoassay Market Surpasses Set to Exceed USD 6.9 Billion by 2032

In a testament to its robust growth trajectory, the global coronavirus immunoassay market has achieved a significant milestone, reaching a valuation of USD 3.7 billion in 2021. Recent market insights indicate a promising outlook for the sector, with forecasts anticipating a Compound Annual Growth Rate (CAGR) of 5.5% during the analysis period, poised to surpass …

Global Coronavirus Immunoassay Market is expected to witness a 5.5% CAGR by 2032, propelled by government policies, as per FMI’s assessment

The global coronavirus immunoassay market size has exhibited remarkable growth, hitting a substantial mark of US$ 3.7 Billion in 2021. According to recent market analyses, this thriving sector is poised for further expansion, foreseeing a robust Compound Annual Growth Rate (CAGR) of 5.5% over the assessment period. Projections suggest an impressive escalation, with the market …

Favorable Government Policies to Support Coronavirus Immunoassay Market Growth to surpass US$ 6.9 Billion by 2032 at a 5.5% CAGR

The Coronavirus Immunoassay Market was worth US$ 3.7 Billion in 2021. By 2032, the market is anticipated to reach a value of approximately US$ 6.9 Billion, with sales increasing at a 5.5% CAGR throughout the assessment period. With an estimated 64.0% market share in 2021, immunoassay kits & reagents are in the lead. COVID-19 has a wide …